These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15792991)

  • 1. Protein kinase C-zeta inhibition exerts cardioprotective effects in ischemia-reperfusion injury.
    Phillipson A; Peterman EE; Taormina P; Harvey M; Brue RJ; Atkinson N; Omiyi D; Chukwu U; Young LH
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H898-907. PubMed ID: 15792991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury.
    Omiyi D; Brue RJ; Taormina P; Harvey M; Atkinson N; Young LH
    J Pharmacol Exp Ther; 2005 Aug; 314(2):542-51. PubMed ID: 15878997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism.
    Young LH; Ikeda Y; Lefer AM
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2489-95. PubMed ID: 11356603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release.
    Young LH; Ikeda Y; Lefer AM
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):107-14. PubMed ID: 11523308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gö 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion.
    Peterman EE; Taormina P; Harvey M; Young LH
    J Cardiovasc Pharmacol; 2004 May; 43(5):645-56. PubMed ID: 15071351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion.
    Young LH; Ikeda Y; Scalia R; Lefer AM
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1453-9. PubMed ID: 11009429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.
    Ikeda Y; Young LH; Scalia R; Ross CR; Lefer AM
    Cardiovasc Res; 2001 Jan; 49(1):69-77. PubMed ID: 11121797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms related to the cardioprotective effects of protein kinase C epsilon (PKC epsilon) peptide activator or inhibitor in rat ischemia/reperfusion injury.
    Teng JC; Kay H; Chen Q; Adams JS; Grilli C; Guglielmello G; Zambrano C; Krass S; Bell A; Young LH
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):1-15. PubMed ID: 18496674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart.
    Campbell B; Shin YK; Scalia R; Lefer AM
    Cardiovasc Res; 1998 Aug; 39(2):393-400. PubMed ID: 9798524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
    Lefer AM; Campbell B; Shin YK; Scalia R; Hayward R; Lefer DJ
    Circulation; 1999 Jul; 100(2):178-84. PubMed ID: 10402448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion.
    Young LH; Ikeda Y; Scalia R; Lefer AM
    J Pharmacol Exp Ther; 2000 Oct; 295(1):37-43. PubMed ID: 10991958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion.
    Pabla R; Buda AJ; Flynn DM; Blessé SA; Shin AM; Curtis MJ; Lefer DJ
    Circ Res; 1996 Jan; 78(1):65-72. PubMed ID: 8603507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.
    Lefer DJ; Scalia R; Campbell B; Nossuli T; Hayward R; Salamon M; Grayson J; Lefer AM
    J Clin Invest; 1997 Feb; 99(4):684-91. PubMed ID: 9045871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism.
    Ikeda Y; Young LH; Scalia R; Lefer AM
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):563-71. PubMed ID: 11196344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats.
    Ikeda Y; Young LH; Lefer AM
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):649-56. PubMed ID: 12658068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion.
    Campbell B; Chuhran CM; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):529-34. PubMed ID: 10599051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury.
    Moon CH; Jung YS; Lee SH; Baik EJ
    Jpn J Physiol; 1999 Oct; 49(5):409-15. PubMed ID: 10603424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart.
    Campbell B; Adams J; Shin YK; Lefer AM
    J Mol Cell Cardiol; 1999 Feb; 31(2):467-76. PubMed ID: 10093058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation.
    Shandelya SM; Kuppusamy P; Weisfeldt ML; Zweier JL
    Circulation; 1993 Feb; 87(2):536-46. PubMed ID: 8381059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.